Your search for tofacitinib returned 12 results

Xeljanz and Xeljanz XR are Janus kinase (JAK) inhibitors indicated to treat moderately to severely active rheumatoid arthritis when methotrexate therapy is inadequate.

Vaccination rates in patients with rheumatoid arthritis remain poor “despite the high rates of infectious disease-related morbidity and mortality,” a review published in Clinical Opinion in Rheumatology has found.